• -
12 Results
A nurse administers a COVID-19 vaccination.
Failures in COVID-19 Vaccine Administration Data Collection Complicated Efforts to Ensure Vaccine Equity in Texas
As the pandemic persisted across the state, did Texans living in cities have better access to Covid-19 vaccines than those in rural areas? How did race or age factor in? The authors assess the successes and shortfalls of Texas' vaccine distribution strategy, and how to do better next time.
Kirstin R.W. Matthews, Rekha Lakshmanan March 4, 2022
Student gets temperature checked at school
Guidance for Parents: Keeping Kids Safe and in School throughout the COVID-19 Pandemic
As the judicial battle over Texas Gov. Greg Abbott’s ban on mask mandates continues, the authors argue that the most effective way to protect children from COVID-19 is to require masks in schools. Click below for their full list of policy recommendations, including what exceptions should be made, and when and how to end school mask requirements.
Quianta Moore, Christopher F. Kulesza December 9, 2021
America’s Children: Responding to the Crisis Now with the Future in Mind
Parental stress, which is heightened during natural disasters, can produce negative physiological responses in the developing brains of their infants and young children. This irreversibly alters the child’s brain structure, impacting their long-term prospects for good health and academic and economic success. Now is the time to institute policies and practices that mitigate the effects of the Covid-19 pandemic on the next generation, write the authors,
Quianta Moore, Christopher Greeley June 30, 2020
A woman sneezes into a tissue.
Improving the Effectiveness of the Annual Flu Vaccine
By Michael W. Deem, Melia E. Bonomo and Kirstin R.W. Matthews Due to the rapidly mutating influenza virus, a new vaccine is usually developed for each flu season. In this policy brief, the authors discuss the current method used by the Centers for Disease Control and Prevention to develop the flu vaccine and propose the use of mathematical modeling to improve the vaccine's effectiveness.
Michael W. Deem, Melia E. Bonomo, Kirstin R.W. Matthews October 29, 2018
Recommendations for the New Administration
This compilation of briefs addresses a range of issues the new administration will face in the coming years.  “It is our hope that these Baker Institute studies will prove to be useful starting points for the new administration to develop comprehensive, forward-looking solutions," said Baker Institute Director Edward Djerejian.
The Baker Institute January 17, 2017
The HPV vaccine saves lives
The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.
Kirstin R.W. Matthews, Monica M. Matsumoto November 17, 2016